DiaMedica Therapeutics, Inc. (DMAC)
7.95
-0.28
(-3.40%)
USD |
NASDAQ |
Feb 27, 16:00
7.93
-0.02
(-0.25%)
After-Hours: 20:00
DiaMedica Therapeutics Research and Development Expense (TTM) : 24.38M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| XOMA Royalty Corp. | 2.295M |
| Avantor, Inc. | -- |
| ACADIA Pharmaceuticals, Inc. | 328.80M |
| Alnylam Pharmaceuticals, Inc. | 1.320B |
| Savara, Inc. | 83.80M |